Terms: = Head and neck cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Prognosis
34 results:
1. Evaluation of a novel model incorporating serological indicators into the conventional TNM staging system for nasopharyngeal carcinoma.
Ding C; Dai DY; Luo ZK; Wang GY; Dong Z; Qin GJ; Du XJ; Ma J
Oral Oncol; 2024 Apr; 151():106725. PubMed ID: 38430711
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative and Postoperative C-Reactive Protein to Albumin Ratio (car) as a Prognostic Marker for Survival of Esophageal Squamous Cell carcinoma Patients After Surgery.
Asaka S; Shimakawa T; Nishiguchi R; Yamaguchi K; Murayama M; Usui T; Yokomizo H; Shiozawa S
Anticancer Res; 2023 Nov; 43(11):5139-5147. PubMed ID: 37909952
[TBL] [Abstract] [Full Text] [Related]
3. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract] [Full Text] [Related]
4. Postoperative inflammatory markers predict survival in patients after McKeown esophagectomy for esophageal cancer.
Takahashi K; Masuda T; Ishikawa Y; Tanishima Y; Kurogochi T; Yuda M; Tanaka Y; Matsumoto A; Yano F; Eto K
J Surg Oncol; 2023 Aug; 128(2):196-206. PubMed ID: 37010064
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic significance of pre- and post-treatment hematological biomarkers in patients with head and neck cancer treated with chemoradiotherapy.
Iwasa YI; Shimizu M; Matsuura K; Hori K; Hiramatsu K; Sugiyama K; Yokota Y; Kitano T; Kitoh R; Takumi Y
Sci Rep; 2023 Mar; 13(1):3869. PubMed ID: 36890182
[TBL] [Abstract] [Full Text] [Related]
6. Gastrointestinal toxicity of systemic oncology immunotherapy.
Bureš J; Kohoutová D; Zavoral M
Klin Onkol; 2022; 35(5):346-357. PubMed ID: 36443091
[TBL] [Abstract] [Full Text] [Related]
7. DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.
Yao J; Bergsland E; Aggarwal R; Aparicio A; Beltran H; Crabtree JS; Hann CL; Ibrahim T; Byers LA; Sasano H; Umejiego J; Pavel M
Oncologist; 2022 Nov; 27(11):940-951. PubMed ID: 35983951
[TBL] [Abstract] [Full Text] [Related]
8. Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab.
Ikoma T; Shimokawa M; Matsumoto T; Boku S; Yasuda T; Shibata N; Kurioka Y; Takatani M; Nobuhisa T; Namikawa T; Kitagawa H; Hanazaki K; Doi K; Shimada T; Tsumura T; Marusawa H; Kanaya S; Morita S; Inokuma T; Nagai H; Yasui H; Satake H
Cancer Immunol Immunother; 2023 Feb; 72(2):427-435. PubMed ID: 35927359
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and safety of camrelizumab in combination with neoadjuvant chemotherapy for ESCC and its impact on esophagectomy.
Qiao Y; Zhao C; Li X; Zhao J; Huang Q; Ding Z; Zhang Y; Jiao J; Zhang G; Zhao S
Front Immunol; 2022; 13():953229. PubMed ID: 35911723
[TBL] [Abstract] [Full Text] [Related]
10. Epstein-Barr virus DNA change level combined with tumor volume reduction ratio after inductive chemotherapy as a better prognostic predictor in locally advanced nasopharyngeal carcinoma.
Xiang ZZ; He T; Zeng YY; Liu F; Shao BF; Yang T; Ma JC; Wang XR; Yu ST; Liu L
Cancer Med; 2023 Jan; 12(2):1102-1113. PubMed ID: 35852473
[TBL] [Abstract] [Full Text] [Related]
11. Development and Validation of a New Integrative Score Based on Various Systemic Inflammatory and Nutritional Indicators in Predicting prognosis in Patients With Resectable Esophageal Squamous Cell carcinoma: A Retrospective Cohort Study.
Feng JF; Wang L; Chen QX; Yang X
Cancer Control; 2022; 29():10732748221091394. PubMed ID: 35410489
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Significance of Nutrition and Inflammation in Esophageal cancer Patients with Surgery: A Meta-Analysis.
Yang Q; Shen A; Chen X; Guo L; Peng H; Gao M
Nutr Cancer; 2022; 74(9):3128-3139. PubMed ID: 35341393
[TBL] [Abstract] [Full Text] [Related]
13. Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
Wang CP; Chen TC; Hsu WL; Hsiao JR; Chen PR; Chen MK; Hua CH; Tsai MH; Ko JY; Lou PJ; Chiang CJ; Wu CT; Chang YL
BMC Cancer; 2022 Mar; 22(1):296. PubMed ID: 35313837
[TBL] [Abstract] [Full Text] [Related]
14. Inflammation-based Prognostic Score as a Prognostic Biomarker in Patients With Recurrent and/or Metastatic head and neck Squamous Cell carcinoma Treated With Nivolumab Therapy.
Matsuo M; Yasumatsu R; Masuda M; Toh S; Wakasaki T; Hashimoto K; Jiromaru R; Manako T; Nakagawa T
In Vivo; 2022; 36(2):907-917. PubMed ID: 35241549
[TBL] [Abstract] [Full Text] [Related]
15. Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis.
Jiang Y; Xu D; Song H; Qiu B; Tian D; Li Z; Ji Y; Wang J
BMJ Open; 2021 Sep; 11(9):e048324. PubMed ID: 34593492
[TBL] [Abstract] [Full Text] [Related]
16. Preoperative C-reactive protein to albumin ratio predicts anastomotic leakage after esophagectomy for thoracic esophageal cancer: a single-center retrospective cohort study.
Sugimoto A; Toyokawa T; Miki Y; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Muguruma K; Yashiro M; Ohira M
BMC Surg; 2021 Sep; 21(1):348. PubMed ID: 34548054
[TBL] [Abstract] [Full Text] [Related]
17. Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC.
Ma Y; Su X; Li X; Zhi X; Jiang K; Xia J; Li H; Yan C; Zhou L
Sci Rep; 2021 Jul; 11(1):15305. PubMed ID: 34315926
[TBL] [Abstract] [Full Text] [Related]
18. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
[TBL] [Abstract] [Full Text] [Related]
19. Association between the C-reactive protein/albumin ratio and prognosis in patients with oral squamous cell carcinoma.
Yamagata K; Fukuzawa S; Ishibashi-Kanno N; Uchida F; Bukawa H
Sci Rep; 2021 Mar; 11(1):5446. PubMed ID: 33686103
[TBL] [Abstract] [Full Text] [Related]
20. Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumab.
Tanoue K; Tamura S; Kusaba H; Shinohara Y; Ito M; Tsuchihashi K; Shirakawa T; Otsuka T; Ohmura H; Isobe T; Ariyama H; Koreishi S; Matsushita Y; Shimokawa H; Tanaka R; Mitsugi K; Akashi K; Baba E
Sci Rep; 2021 Feb; 11(1):2741. PubMed ID: 33531609
[TBL] [Abstract] [Full Text] [Related]
[Next]
